The effects of titania nanotubes with embedded silver oxide nanoparticles on bacteria and osteoblasts

Biomaterials

Volumn 35, Issue 13, 2014, Pages 4223-4235

  Gao, Ang ^a   Hang, Ruiqiang ^a   Huang, Xiaobo ^a   Zhao, Lingzhou ^b   Zhang, Xiangyu ^a   Wang, Lin ^c   Tang, Bin ^a   Ma, Shengli ^d   Chu, Paul K ^e  

^a TAIYUAN UNIVERSITY OF TECHNOLOGY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NINGBO UNIVERSITY OF TECHNOLOGY   (China)

^d XI'AN JIAOTONG UNIVERSITY   (China)

^e CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anodization; Antibacterial activity; Osteoblasts

Indexed keywords

BINARY ALLOYS; BIOMATERIALS; CYTOTOXICITY; ESCHERICHIA COLI; NANOTUBES; OSTEOBLASTS; SILVER NANOPARTICLES; SILVER OXIDES; TITANIUM DIOXIDE; YARN;

ANODIZATIONS; ANTI-BACTERIAL ACTIVITY; BIOMEDICAL COATINGS; BIOMEDICAL FIELDS; CONTROLLED RELEASE; SILVER OXIDE NANOPARTICLES; STAPHYLOCOCCUS AUREUS; TITANIA NANOTUBES;

CHROMIUM COMPOUNDS;

NANOTUBE; SILVER NANOPARTICLE; SILVER OXIDE NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE; TITANIUM DIOXIDE NANOTUBE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DISILVER OXIDE; OXIDE; SILVER DERIVATIVE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SPREADING; CELL STRUCTURE; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTALLIZATION; CYTOTOXICITY; ESCHERICHIA COLI; IMMERSION; MICROWAVE OVEN; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; CHEMISTRY; DRUG EFFECTS; ESCHERICHIA;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ESCHERICHIA; NANOTUBES; OSTEOBLASTS; OXIDES; SILVER COMPOUNDS; STAPHYLOCOCCUS AUREUS; TITANIUM;

EID: 84896723566     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.058     Document Type: Article

References (53)

1. Darouiche R.O. Treatment of infections associated with surgical implants. New Engl J Med 2004, 350:1422-1429.
2. Costerton J.W. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
3. Zhao L., Chu P.K., Zhang Y., Wu Z. Antibacterial coatings on titanium implants. JBiomed Mater Res B 2009, 91:470-480.
4. Li X., Wang L., Fan Y., Feng Q., Cui F.Z., Watari F. Nanostructured scaffolds for bone tissue engineering. JBiomed Mater Res A 2013, 101:2424-2435.
5. Gong D., Grimes C., Varghese O.K., Hu W., Singh R., Chen Z., et al. Titanium oxide nanotube arrays prepared by anodic oxidation. JMater Res 2001, 16:3331-3334.
6. 2 nanotubes: synthesis and applications. Angew Chem Int Ed 2011, 50:2904-2939.
7. 2 nanotube surfaces. Nano Lett 2008, 8:786-793.
8. 2 nanotubes on endothelial function and smooth muscle proliferation. Biomaterials 2009, 30:1268-1272.
9. 2 nanotube surfaces. Nano Lett 2009, 9:3157-3164.
10. Oh S., Brammer K.S., Li Y.S., Teng D., Engler A.J., Chien S., et al. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A 2009, 106:2130-2135.
11. Zhao L., Liu L., Wu Z., Zhang Y., Chu P.K. Effects of micropitted/nanotubular titania topographies on bone mesenchymal stem cell osteogenic differentiation. Biomaterials 2012, 33:2629-2641.
12. Li X., Liu H., Niu X., Yu B., Fan Y., Feng Q., et al. The use of carbon nanotubes to induce osteogenic differentiation of human adipose-derived MSCs in vitro and ectopic bone formation in vivo. Biomaterials 2012, 33:4818-4827.
13. Popat K.C., Leoni L., Grimes C.A., Desai T.A. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials 2007, 28:3188-3197.
14. 2 nanotube surface. Acta Biomater 2009, 5:3215-3223.
15. 2 nanotubes for bone regeneration. Trends Biotechnol 2012, 30:315-322.
16. 2 nanotubes with different diameters on gene expression and osseointegration of implants in minipigs. Biomaterials 2011, 32:6900-6911.
17. Popat K.C., Eltgroth M., Latempa T.J., Grimes C.A., Desai T.A. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007, 28:4880-4888.
18. 2 nanotube arrays for peri-implant infections. JBiomed Mater Res A 2012, 100A:278-285.
19. Chernousova S., Epple M. Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed 2013, 52:1636-1653.
20. Silver S., Phung L.T., Silver G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. JInd Microbiol Biotechnol 2006, 33:627-634.
21. Klasen H. Ahistorical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000, 26:131-138.
22. Rupp M.E., Fitzgerald T., Marion N., Helget V., Puumala S., Anderson J.R., et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control 2004, 32:445-450.
23. Samuel U., Guggenbichler J.P. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 2004, 23(Suppl.1):S75-S78.
24. Strathmann M., Wingender J. Use of an oxonol dye in combination with confocal laser scanning microscopy to monitor damage to Staphylococcus aureus cells during colonisation of silver-coated vascular grafts. Int J Antimicrob Agents 2004, 24:234-240.
25. Bosetti M., Masse A., Tobin E., Cannas M. Silver coated materials for external fixation devices: invitro biocompatibility and genotoxicity. Biomaterials 2002, 23:887-892.
26. Wassall M., Santin M., Isalberti C., Cannas M., Denyer S. Adhesion of bacteria to stainless steel and silver-coated orthopedic external fixation pins. JBiomed Mater Res A 1998, 36:325-330.
27. Zhao L., Wang H., Huo K., Cui L., Zhang W., Ni H., et al. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 2011, 32:5706-5716.
28. Owens D.K., Wendt R. Estimation of the surface free energy of polymers. JAppl Polym Sci 1969, 13:1741-1747.
29. Neoh K.G., Hu X., Zheng D., Kang E.T. Balancing osteoblast functions and bacterial adhesion on functionalized titanium surfaces. Biomaterials 2012, 33:2813-2822.
30. 2 nanotubes from columnar titanium thin films sputtered on semiconductor surfaces. Electrochem Commun 2006, 8:1840-1844.
31. Musil J., Vlček J. Magnetron sputtering of alloy and alloy-based films. Thin Solid Films 1999, 343:47-50.
32. Alt V., Bechert T., Steinrucke P., Wagener M., Seidel P., Dingeldein E., et al. An invitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004, 25:4383-4391.
33. Kumar R., Howdle S., Munstedt H. Polyamide/silver antimicrobials: effect of filler types on the silver ion release. JBiomed Mater Res B 2005, 75:311-319.
34. Hetrick E.M., Schoenfisch M.H. Reducing implant-related infections: active release strategies. Chem Soc Rev 2006, 35:780-789.
35. Feng Q., Wu J., Chen G., Cui F., Kim T., Kim J. Amechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. JBiomed Mater Res 2000, 52:662-668.
36. Yamanaka M., Hara K., Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol 2005, 71:7589-7593.
37. Yang W., Shen C., Ji Q., An H., Wang J., Liu Q., et al. Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology 2009, 20:085102.
38. Jung W.K., Koo H.C., Kim K.W., Shin S., Kim S.H., Park Y.H. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microb 2008, 74:2171-2178.
39. Marambio-Jones C., Hoek E.M. Areview of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. JNanopart Res 2010, 12:1531-1551.
40. Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E.coli as a model for Gram-negative bacteria. JColloid Interface Sci 2004, 275:177-182.
41. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramírez J.T., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346.
42. Stoimenov P.K., Klinger R.L., Marchin G.L., Klabunde K.J. Metal oxide nanoparticles as bactericidal agents. Langmuir 2002, 18:6679-6686.
43. Huo K., Zhang X., Wang H., Zhao L., Liu X., Chu P.K. Osteogenic activity and antibacterial effects on titanium surfaces modified with Zn-incorporated nanotube arrays. Biomaterials 2013, 34:3467-3478.
44. Greulich C., Diendorf J., Simon T., Eggeler G., Epple M., Köller M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 2011, 7:347-354.
45. Park E.-J., Yi J., Kim Y., Choi K., Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol InVitro 2010, 24:872-878.
46. Chen X., Schluesener H. Nanosilver: a nanoproduct in medical application. Toxicol Lett 2008, 176:1-12.
47. Kawata K., Osawa M., Okabe S. Invitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 2009, 43:6046-6051.
48. Zhao L., Wang H., Huo K., Zhang X., Wang W., Zhang Y., et al. The osteogenic activity of strontium loaded titania nanotube arrays on titanium substrates. Biomaterials 2013, 34:19-29.
49. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004, 6:483-495.
50. Civitelli R. Cell-cell communication in the osteoblast/osteocyte lineage. Arch Biochem Biophys 2008, 473:188-192.
51. Stains J.P., Civitelli R. Cell-cell interactions in regulating osteogenesis and osteoblast function. Birth Defects Res C 2005, 75:72-80.
52. Gristina A.G. Biomaterial-centered infections: microbial adhesion versus tissue integration. Science 1987, 237:1588-1595.
53. Arnell R., Kelly P. Recent advances in magnetron sputtering. Surf Coat Tech 1999, 112:170-176.